Filtered By:
Vaccination: Covid Vaccine
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 848 results found since Jan 2013.
Nonepisodic angioedema with eosinophilia after COVID-19 vaccination: a case successfully treated with reslizumab
Angioedema with eosinophilia (AE) is a rare allergic disease classified as episodic or nonepisodic. AE is characterized by angioedema, urticaria, fever, weight gain, and eosinophilia, but its etiology and path...
Source: Allergy, Asthma and Clinical Immunology - February 2, 2023 Category: Allergy & Immunology Authors: Young-Hee Nam Tags: Case report Source Type: research
Allergy to Omalizumab: Lessons from a Reaction to the Coronavirus 2019 Vaccine
Intern Med. 2023 Feb 1. doi: 10.2169/internalmedicine.1169-22. Online ahead of print.ABSTRACTOmalizumab can cause hypersensitivity reactions. We herein report the first case of an 18-year-old woman with refractory cough-predominant asthma that correlated with allergic reactions caused by omalizumab and the coronavirus disease 2019 (COVID-19) vaccine. The patient developed angioedema after taking omalizumab. She had previously experienced intense coughing immediately after receiving a COVID-19 vaccine. A skin prick test was positive for polysorbate 20, which was probably the cause of the allergic reactions to omalizumab and...
Source: Internal Medicine - February 1, 2023 Category: Internal Medicine Authors: Takeshi Matsumoto Yumiko Sakurai Takahiro Fujiki Yusuke Kusakabe Emi Nakayama Ayaka Tanaka Naoki Yamamoto Kensaku Aihara Shinpachi Yamaoka Michiaki Mishima Source Type: research
Urticaria After COVID-19 Vaccination and Vaccine Hesitancy
COVID-19 vaccination efforts continue to curb the pandemic, but 1-2% of individuals experience post-vaccination rashes and are less likely to complete all recommended vaccine doses. We sought to quantify the impact of urticaria after COVID-19 vaccination on quality of life and vaccine hesitancy.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Kimberly Blumenthal, Allen Judd, Upeka Samarakoon, Esther Freeman Source Type: research
Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency
Given limited data regarding response to SARS-CoV-2 immunization in pediatric patients with predominant antibody deficiency (PAD), we sought to assess the anti-SARS-CoV-2-spike antibody response, and vaccine safety and tolerability in pediatric PAD patients.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Megha Tandon, Daniel DiGiacomo, Chen Rosenberg, Paul Hesterberg, Sara Barmettler, Jocelyn Farmer Source Type: research
Kinetics of Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Doses in Patients With Predominant Antibody Deficiency
Anti-spike antibody levels following initial series SARS-CoV-2 immunization are lower in patients with predominant antibody deficiency (PAD) compared to healthy controls. However, the kinetics of vaccine response to SARS-CoV-2 immunization in PAD patients is unknown, especially as additional immunizations have been recommended by the CDC as the pandemic has evolved.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Daniel DiGiacomo, Megha Tandon, Baijun Zhou, Jocelyn Farmer, Sara Barmettler Source Type: research
Antibody and T-cell responses to COVID-19 Vaccination in Common Variable Immunodeficiency and Specific Antibody Deficiency
Clinical trials of the mRNA COVID-19 vaccines excluded individuals with primary antibody deficiencies.
Source: Annals of Allergy, Asthma and Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Jamie A. Rosenthal, Michelle Premazzi Papa, Marta Sanz, Samuel Nicholes, Carissa Stower, Alberto Bosque, Anjeni Keswani, Richard Amdur, Rebecca M. Lynch, Natalia Soriano-Sarabia, Daniel Ein Tags: Original Article Source Type: research
Subacute Onset of Chronic Urticaria Post COVID-19 Vaccination
Urticaria has been known to be triggered for a variety of allergy and non-allergic etiologies. Autoimmune disease, infection, and immunizations can be considered as possible underlying differentials for non-allergic urticarial eruption. I hypothesized that a subacute onset of chronic urticarial eruptions and/or demographic state was also possibly attributable to COVID-19 vaccinations in select patients observed at a single allergy and immunology practice.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Kristy Semenza Source Type: research
Development Of A Clinical Predictive Score For Allergic Reactions To COVID-19 Vaccine (AZD1222)
COVID-19 vaccine hypersensitivity reaction is an important issue that associated with COVID-19 vaccine hesitancy for patients ’ preference and physician advice. Validated clinical decision rules are in needed to identify individuals who may develop allergic reaction following vaccination. We aimed to develop a predictive score for allergic reactions to COVID-19 vaccine.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Karnsinee Thanborisutkul, Patcharaporn Punyashthira, Sira Nantapisal, Orapan Poachanukoon, Phichayut Phinyo, Prapasri Kulalert Source Type: research
Delayed Cutaneous Reactions Following COVID-19 Vaccinations – A Military Cohort Analysis
The objective of this study is to determine if delayed cutaneous reactions are reported with more frequency following a COVID-19 vaccine than with other vaccinations.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Charles Miller, Catherine Skerrett, James Quinn Source Type: research
COVID-19 mRNA Vaccine-induced Immunization Stress-Related Response (ISRR) and Anaphylaxis: An Early Look at COVAAR Clinical Outcomes
COVID-19 mRNA vaccine anaphylaxis has been estimated to occur at a higher rate compared to conventional vaccines. We aimed to assess safety of subsequent dose administration in individuals who experienced a systemic allergic reaction after 1st dose of an mRNA vaccine.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Muhammad Khalid, Joanna Utoh, Ellen Zektser, Pamela Guerrerio Source Type: research
